Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MYCOPHENOLATE MOFETIL, with a corresponding US DMF Number 16406.
Remarkably, this DMF maintains an Active status since its submission on January 20, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 17, 2018, and payment made on August 10, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II